Vaccine News and Research

Latest Vaccine News and Research

Evaluating the efficacy of third dose booster vaccine against SARS-CoV-2 in patients with cancer

A new editorial paper was published in Oncoscience (Volume 10) on September 1, 2023, entitled, "Exiting the pandemic together: achieving global immunity and equity."

8 Sep 2023

Study reports an increase in incidence of islet autoimmunity after SARS-CoV-2 infection in young children

Type 1 diabetes is an autoimmune disease leading to an impaired glucose metabolism and requires life-long administration of insulin.

8 Sep 2023

Latest updates on SARS-CoV-2 variants identified in the UK

The UK Health Security Agency (UKHSA) has published SARS-CoV-2 variant surveillance and assessment technical briefing 53. It contains the latest epidemiological and genomic analysis of the emergent BA.2.86 variant.

8 Sep 2023

Annual NHS flu vaccination program for children is getting underway

The annual NHS flu vaccination program for children aged 2 to 3 years, school age children and children over 6 months with certain health conditions is getting underway. Parents will receive invites from next week.

8 Sep 2023

The shrinking number of primary care physicians is reaching a tipping point

I've been receiving an escalating stream of panicked emails from people telling me their longtime physician was retiring, was no longer taking their insurance, or had gone concierge and would no longer see them unless they ponied up a hefty annual fee.

8 Sep 2023

In move to slash CDC budget, House Republicans target major HIV program Trump launched

More than four years ago, then-President Donald Trump declared an ambitious goal that had bipartisan support: ending the HIV epidemic in the United States.

8 Sep 2023

Global case series uncovers Mpox resurgence among previously infected or fully vaccinated individuals

Researchers elucidated monkeypox's (mpox) epidemiological and clinical features.

8 Sep 2023

Self-adjuvanting RNA vaccines boost immune response 10x more than existing vaccines

RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better.

8 Sep 2023

Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Recently published research from the University of Minnesota Medical School suggests individuals with hepatitis C should consider revaccination for hepatitis B. The study was published in the Journal of Infectious Diseases.

8 Sep 2023

Novel test could improve detection of cervical adenocarcinoma

In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center (MECC) have developed a test for detecting a type of cervical cancer that Pap tests often miss.

7 Sep 2023

BA.2.86 Omicron variant: Is our immunity under siege?

A new preprint posted to the bioRxiv server discusses whether this variant shows neutralization escape.

7 Sep 2023

Amish-populated counties tend to have lower vaccination rates, but are not unvaccinated

This summer, viral misinformation claimed that the Amish did not vaccinate against COVID-19 and, as a result, had a death rate 90 times lower than the rest of the United States.

7 Sep 2023

Scientists elucidate mechanism behind early loss of vaccination protection in people with autoimmune disease

People who are treated with TNF-α inhibitors for their autoimmune disease such as Crohn's disease or rheumatoid arthritis lose their vaccination protection significantly earlier than average.

7 Sep 2023

One in three men carry HPV: The ignored reservoir in the fight against cancer

One in three men over 15 globally have at least one incidence of genital HPV, underscoring the need to include males in HPV prevention strategies. The prevalence remains high from young adulthood through later life, particularly for high-risk HPV types linked to cancers.

6 Sep 2023

Study characterizes SARS-CoV-2 Omicron BA.2.86: New variant under watch

Researchers identify a new SARS-CoV-2 variant, BA.2.86, with enhanced ability to evade immunity but lower infectivity compared to current variants. The study highlights the need for global monitoring due to its potential to become a predominant strain if it gains infectivity through mutations.

6 Sep 2023

Using ChatGPT to address vaccine hesitancy: a promising tool for guiding users to scientific information?

Researchers assessed ChatGPT's ability to address the 50 most common misconceptions about vaccine safety.

6 Sep 2023

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Researchers at Washington University have demonstrated that early life exposure to multiple viruses in house mice dampens the immune response to SARS-CoV-2 vaccinations later in life. The study raises concerns about the applicability of common mouse models in immunological research, suggesting that prior pathogen exposure could be a significant variable in predicting vaccine efficacy.

5 Sep 2023

Monovalent vaccine outperforms bivalent in fighting new Omicron variants

New U.S. study finds mRNA-1273.815, a monovalent vaccine targeting the Omicron XBB.1.5 variant, generates higher neutralizing antibody titers compared to its bivalent counterpart. The study supports updating to an XBB.1.5-based monovalent vaccine for the 2023-24 campaign to combat emerging variants.

5 Sep 2023

World-renowned Diamond Light Source facility to be upgraded through a £500 million investment

A groundbreaking science facility which kickstarted the UK's world leading Covid drug development and has advanced treatments of global health challenges from HIV to malaria and cancer will be upgraded and expanded through a more than £500 million investment, Science and Technology Secretary Michelle Donelan has announced today (Wednesday 6 September).

5 Sep 2023

Novavax's updated XBB.1.5 vaccine shows promising cross-neutralizing antibodies against new COVID-19 variants

The study reveals that Novavax's updated XBB.1.5 vaccine effectively induces cross-neutralizing antibodies against multiple Omicron XBB sub-variants in both mice and non-human primates.

5 Sep 2023

Previous
1
...
76
77
78
79
80
81
82
...
1141
Next

Vaccine News and Research

Latest Vaccine News and Research

Evaluating the efficacy of third dose booster vaccine against SARS-CoV-2 in patients with cancer

Study reports an increase in incidence of islet autoimmunity after SARS-CoV-2 infection in young children

Latest updates on SARS-CoV-2 variants identified in the UK

Annual NHS flu vaccination program for children is getting underway

The shrinking number of primary care physicians is reaching a tipping point

In move to slash CDC budget, House Republicans target major HIV program Trump launched

Global case series uncovers Mpox resurgence among previously infected or fully vaccinated individuals

Self-adjuvanting RNA vaccines boost immune response 10x more than existing vaccines

Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Novel test could improve detection of cervical adenocarcinoma

BA.2.86 Omicron variant: Is our immunity under siege?

Amish-populated counties tend to have lower vaccination rates, but are not unvaccinated

Scientists elucidate mechanism behind early loss of vaccination protection in people with autoimmune disease

One in three men carry HPV: The ignored reservoir in the fight against cancer

Study characterizes SARS-CoV-2 Omicron BA.2.86: New variant under watch

Using ChatGPT to address vaccine hesitancy: a promising tool for guiding users to scientific information?

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Monovalent vaccine outperforms bivalent in fighting new Omicron variants

World-renowned Diamond Light Source facility to be upgraded through a £500 million investment

Novavax's updated XBB.1.5 vaccine shows promising cross-neutralizing antibodies against new COVID-19 variants

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in